Corewell Health

Running trials

• Recruiting

  A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

  NCT07723963· Phase 2/3· Source

• Recruiting

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· Phase 3· Source

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  NCT07166094· Phase 3· Source

• Recruiting

  BoxX-NoAF Clinical Trial

  NCT06989775· Source

• Recruiting

  Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

  NCT07069738· Source

• Recruiting

  AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

  NCT06959524· Source

• Recruiting

  This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  NCT06758401· Phase 3· Source

• Active, not recruiting

  A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

  NCT06888921· Phase 1/2· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

  NCT06450639· Phase 2· Source

• Recruiting

  Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  NCT06819007· Phase 3· Source

• Recruiting

  Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

  NCT06806033· Phase 2· Source

• Recruiting

  Prevail Global Study

  NCT06535854· Source

• Active, not recruiting

  SIMPLAAFY Clinical Trial

  NCT06521463· Source

• Recruiting

  VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

  NCT06264180· Phase 3· Source

• Recruiting

  AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

  NCT06063850· Phase 1/2· Source

• Recruiting

  Tracking Results of Ablations to Combat AF Registry Generation 2

  NCT05111015· Source

• Active, not recruiting

  Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

  NCT06096337· Source

• Active, not recruiting

  A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study

  NCT07045103· Source

• Recruiting

  Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  NCT06056830· Phase 3· Source

• Active, not recruiting

  Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06029972· Phase 2· Source

• Recruiting

  Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

  NCT05919511· Source

• Recruiting

  Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  NCT05734066· Phase 1/2· Source

• Recruiting

  Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  NCT05826535· Phase 1/2· Source

• Active, not recruiting

  Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

  NCT05478304· Source

• Recruiting

  AngelMed Guardian® System PMA Post Approval Study

  NCT05412927· Source

• Recruiting

  Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

  NCT05102019· Source

• Active, not recruiting

  Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

  NCT04763200· Source

• Recruiting

  Medtronic Terminate AF Study

  NCT03546374· Source

• Enrolling by invitation

  Improving the Quality of Care for Adults With Inflammatory Bowel Disease

  NCT02791854· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation3 recruiting
• Coronary artery disease3 recruiting
• Childhood cancers2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Epilepsy2 recruiting
• Follicular lymphoma2 recruiting
• Heart failure2 recruiting
• Crohn's disease1 recruiting
• Endometrial cancer1 recruiting
• Hodgkin lymphoma1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Prostate cancer1 recruiting
• Sarcoma1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

  NCT06543446· Source

• Completed

  HEAL-LAA Clinical Trial

  NCT05809596· Source

• Terminated

  A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

  NCT05336409· Phase 1· Source

• Terminated

  A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors

  NCT05346484· Phase 1· Source

• Completed

  CureDuchenne Link®: A Resource for Research

  NCT04972604· Source